Cost-Effectiveness Analysis of Patiromer in Combination with Renin-Angiotensin-Aldosterone System Inhibitors for Chronic Kidney Disease in Sweden.

Saved in:
Bibliographic Details
Title: Cost-Effectiveness Analysis of Patiromer in Combination with Renin-Angiotensin-Aldosterone System Inhibitors for Chronic Kidney Disease in Sweden.
Authors: Widén J; Quantify Research AB, Stockholm, Sweden. info@quantifyresearch.com., Ivarsson M; Vifor Pharma Nordiska AB, Stockholm, Sweden., Schalin L; Vifor Pharma Nordiska AB, Stockholm, Sweden., Vrouchou P; Vifor Pharma Ltd, Glattbrugg, Switzerland., Schwenkglenks M; Institute of Pharmaceutical Medicine (ECPM), University of Basel, Basel, Switzerland., Heimbürger O; Patient Area Endocrinology and Renal Medicine, Karolinska University Hospital, Stockholm, Sweden.; CLINTEC, Karolinska Institutet, Stockholm, Sweden., Ademi Z; Institute of Pharmaceutical Medicine (ECPM), University of Basel, Basel, Switzerland.; School of Public Health and Preventive Medicine (SPHPM), Monash University, Melbourne, Australia., Sutherland CS; Institute of Pharmaceutical Medicine (ECPM), University of Basel, Basel, Switzerland.
Source: PharmacoEconomics [Pharmacoeconomics] 2020 Jul; Vol. 38 (7), pp. 747-764.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9212404 Publication Model: Print Cited Medium: Internet ISSN: 1179-2027 (Electronic) Linking ISSN: 11707690 NLM ISO Abbreviation: Pharmacoeconomics
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1179-2027
DOI:10.1007/s40273-020-00902-w